EBITDA

A new partnership between HCPro and ZHealth aims to solve the costly, error-prone challenge of specialty coding in radiology and cardiology. Here’s why.

Munters plans to divest its high-growth FoodTech arm, Speria, to double down on its data center and air treatment businesses in a classic strategic move.

While luxury sales and global cash flood Miami, a tale of two markets emerges, challenging local affordability and reshaping the city's future.

A landmark court ruling forces a recall of Siemens' latest mammography tech, handing Hologic a major victory and sending shockwaves through Europe's MedTech.

As a rare Ebola strain rages in a DRC warzone, the G7 pledges massive aid. But with fragile peace deals and no proven cure, is it enough to stop a global crisis?

Beyond the scorecard, the real game-changer on the golf course is battery tech. Vipboss's new solution highlights a shift to lithium that promises major ROI.

For the fifth year, Planview leads in strategic management. But its real story is how it uses AI to help firms move fast without losing their way.

ICL Group's successful $800M notes offering signals strong investor confidence, securing long-term capital to fund its strategic shift into specialty products.

Diversified Royalty Corp. moves beyond its traditional model with a $235M acquisition of the Mr. Lube franchisor, signaling a major strategic shift.

A major private equity investment in CaseWorthy signals a new era for human services tech, promising AI-driven efficiency. But can profit motives scale compassion?

A forgotten corner of oncology is set for a 14.2% CAGR. A new wave of drugs for chemo-induced neuropathy signals a major market realignment.

The XR market is pivoting. Bulky headsets are out, and sleek, everyday glasses are in. Discover the forces driving this change and what it means for tech.

Insurers promise big savings for bundling policies, but in high-risk zones like Florida, this convenience can mask dangerous coverage gaps. Here's the real story.

A new report shows Blue Cross Blue Shield plans have slashed administrative cost growth, a sign of rare efficiency. But what does this mean for your wallet?

A new alliance between Meritus Capital and Republic Business Credit aims to solve a critical cash flow problem for the temporary staffing industry.

With a novel non-hallucinogenic drug, Enveric Biosciences heads to the BIO convention seeking partners. Can its unique science secure its future?

Terreno Realty's latest acquisition in Alexandria isn't just another deal. It's a calculated move in a tight market, revealing a deep strategy for a future where last-mile logistics is king.

GTIA's inaugural Innovate Awards move past AI hype, showcasing six firms whose practical solutions are already transforming the IT channel's efficiency and impact.

A Quebec startup's strategic hires reveal a critical shift in the quantum race, where translating science into value is now as vital as the breakthroughs themselves.

In a tough fundraising climate, Clearlake Capital's massive $14.8B close isn't just a win; it's a strategic bet on the AI-driven future of industry.